Therapeutic Targeting of Non-Oncogene Dependencies in High-Risk Neuroblastoma.

CONCLUSIONS: Our results establish a gene-expression-based strategy to interrogate cancer biology and inform drug discovery and repositioning for high-risk neuroblastoma. PMID: 30952635 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30952635?dopt=Abstract

Source: Clinical Cancer Research - April 4, 2019 Category: Cancer & Oncology Authors: Huang CT, Hsieh CH, Lee WC, Liu YL, Yang TS, Hsu WM, Oyang YJ, Huang HC, Juan HF Tags: Clin Cancer Res Source Type: research